 |
Journal articles
Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis
Abstract : Caspases are aspartate-specific cysteine proteases that play a pivotal role in drug-induced cell death. We designed RT-PCR assays to analyse the expression of CASP-3, CASP-4, CASP-6 and the long and short isoforms of CASP-2 genes in human cells. These genes heterogeneously coexpress in leukemic cell lines and bone marrow samples from patients with de novo acute myelogenous leukemia at diagnosis. Treatment of U937 and HL60 leukemic cells and HT29 colon carcinoma cells with the topoisomerase II inhibitor etoposide upregulates CASP-2 and CASP-3 genes in these cells before inducing their apoptosis. This effect of etoposide is not observed in K562 cells and bcl-2-transfected U937 cells which are less sensitive to drug-induced apoptosis. Nuclear run-on experiments demonstrate that etoposide increases CASP gene transcription in U937 cells, an effect that is prevented by Bcl-2 overexpression. Upregulation of CASP genes is associated with an enhanced synthesis of related procaspases that precedes the appearance of apoptosis markers including caspase-3 activation, poly(ADP-ribose) polymerase cleavage and internucleosomal DNA fragmentation. These results suggest that the ability of tumor cells to upregulate CASP-2 and CASP-3 genes in response to cytotoxic drugs could be predictive of their sensitivity to drug-induced apoptosis.
https://www.hal.inserm.fr/inserm-02345506
Contributor : Beatrice Eymin Connect in order to contact the contributor
Submitted on : Monday, November 4, 2019 - 3:23:36 PM
Last modification on : Monday, October 11, 2021 - 2:22:28 PM
Contributor : Beatrice Eymin Connect in order to contact the contributor
Submitted on : Monday, November 4, 2019 - 3:23:36 PM
Last modification on : Monday, October 11, 2021 - 2:22:28 PM
Links full text
